Shoulder Innovations, Inc. (SI) Cash Flow Statement

NYSE: SIOperating cash, capex, free cash flow and buybacks.

Where SI’s cash came from and went, 2025

December 31, 2025 · U.S. dollars
Cash from operations
−$28.6M
Capital expenditures
$7.4M
15.7% of revenue
Free cash flow
−$36.0M
−76.1% margin
Returned to shareholders
—
Change in cash
$20.7M
cash at year-end $26.9M
Shares issued: $143.6MShares issued$143.6MOther financing: $1.4MOther financing$1.4MInvestments (net): $88.2MInvestments (net)$88.2M · 61%Cash used in operations: $28.6MCash used in operations$28.6M · 20%Capital expenditures: $7.4MCapital expenditures$7.4M · 5%Added to cash: $20.7MAdded to cash$20.7M · 14%$145.0M
Cash from operations
−$28.6M
Capital expenditures
−$7.4M
Investments (net)
−$88.2M
Shares issued
+$143.6M
Other financing
+$1.4M
Change in cash
$20.7M

Drawn to scale: where the cash came from and how it was used. Hover for values.

SI operating cash flow, capex and free cash flow

Operating cash flowCapital expendituresFree cash flowFCF margin (right axis)

SI cash flow trends, 2023–2025

Shoulder Innovations, Inc. cash flow trends
MetricTrendThenLatestChange
Operating cash flow−$13.1M2023−$28.6M2025—
Capital expenditures$2.7M2023$7.4M2025+64.2%/yr
Free cash flow−$15.9M2023−$36.0M2025—
Free cash flow margin−82.5%2023−76.1%2025+6.3 pts
Stock-based compensation$451,0002023$996,0002025+48.6%/yr
Capex / revenue14.3%202315.7%2025+1.4 pts

Change is the average annual growth (CAGR) or the difference between the first and latest year.

SI cash flow by activity

OperatingInvestingFinancingChange in cash

SI net income vs operating cash flow

Net incomeOperating cash flow

Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).

SI cash flow statement

Shoulder Innovations, Inc. annual cash flow statement
202520242023
Operating activities
Net income−$40.4M−$15.6M−$12.7M
Depreciation & amortization$3.2M$2.2M$1.6M
Stock-based compensation$996,000$754,000$451,000
Change in working capital−$6.8M−$1.0M−$4.8M
Other non-cash items$14.3M−$437,000$2.2M
Cash from operating activities−$28.6M−$14.1M−$13.1M
Investing activities
Capital expenditures−$7.4M−$4.0M−$2.7M
Investments (net)−$88.2M$18.0M−$26.2M
Acquisitions & other investing$0$0$0
Cash from investing activities−$95.6M$14.0M−$29.0M
Financing activities
Net borrowing (repayment)—$0$10.0M
Shares issued$143.6M$0$34.9M
Other financing$1.4M$66,000−$149,000
Cash from financing activities$145.0M$66,000$44.7M
Summary
Net change in cash$20.7M−$113,000$2.6M
Cash at end of period$26.9M$6.1M$6.2M
Free cash flow−$36.0M−$18.2M−$15.9M
Free cash flow margin−76.1%−57.4%−82.5%
Capex / revenue15.7%12.7%14.3%

Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.

SI cash generation

In fiscal 2025 (ended December 31, 2025), Shoulder Innovations generated -$28.6 million of cash from operations and spent $7.4 million on capital expenditures, leaving free cash flow of -$36.0 million, −76.1% of revenue. Cash and equivalents rose by $20.7 million over the year.

Related: SI income statement, SI balance sheet. See the SI stock overview for the latest quote and news.

SI cash flow FAQ

What is Shoulder Innovations's free cash flow?

Shoulder Innovations's free cash flow was -$36.0 million in fiscal 2025: -$28.6 million of operating cash flow minus $7.4 million of capital expenditures It was -$18.2 million a year earlier..

How much cash does Shoulder Innovations generate from operations?

Shoulder Innovations generated -$28.6 million of cash from operating activities in fiscal 2025.

How much does Shoulder Innovations spend on capital expenditures?

Shoulder Innovations spent $7.4 million on capital expenditures in fiscal 2025, 15.7% of revenue, compared with $4.0 million the year before.

Healthcare: cash flow